| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3864367 | The Journal of Urology | 2011 | 7 Pages |
Abstract
Prostate specific antigen decreased after switching luteinizing hormone-releasing hormone therapies. This decrease appeared most significant in the group that switched from leuprolide acetate to goserelin. The duration of response after switching was approximately 5 months. The study is limited by its retrospective nature but should encourage prospective evaluation of this observation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Nathan Lawrentschuk, Kimberly Fernandes, David Bell, Jack Barkin, Neil Fleshner,